Log in

Sorrento Therapeutics News Headlines (NASDAQ:SRNE)

$1.53
-0.11 (-6.71 %)
(As of 10/20/2019 08:28 AM ET)
Today's Range
$1.51
Now: $1.53
$1.64
50-Day Range
$1.50
MA: $2.08
$2.51
52-Week Range
$1.39
Now: $1.53
$6.50
Volume1.38 million shs
Average Volume2.31 million shs
Market Capitalization$204.27 million
P/E RatioN/A
Dividend YieldN/A
Beta2.4

Headlines

Sorrento Therapeutics (NASDAQ SRNE) News Headlines

Source:
DateHeadline
Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move ForwardLos Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward
finance.yahoo.com - October 15 at 11:33 PM
Short Interest in Sorrento Therapeutics Inc (NASDAQ:SRNE) Grows By 10.1%Short Interest in Sorrento Therapeutics Inc (NASDAQ:SRNE) Grows By 10.1%
www.americanbankingnews.com - October 14 at 11:38 PM
Sorrento Therapeutics Announces Closing of $25 Million Registered Direct OfferingSorrento Therapeutics Announces Closing of $25 Million Registered Direct Offering
finance.yahoo.com - October 9 at 1:30 PM
Sorrento Therapeutics (NASDAQ:SRNE) Coverage Initiated at JMP SecuritiesSorrento Therapeutics (NASDAQ:SRNE) Coverage Initiated at JMP Securities
www.americanbankingnews.com - October 8 at 3:10 AM
Sorrento down 22% on equity offeringSorrento down 22% on equity offering
seekingalpha.com - October 7 at 6:37 PM
Sorrento Therapeutics Announces $25 Million Registered Direct OfferingSorrento Therapeutics Announces $25 Million Registered Direct Offering
finance.yahoo.com - October 7 at 6:37 PM
SRNE.P - Sorrento Therapeutics Inc Profile | ReutersSRNE.P - Sorrento Therapeutics Inc Profile | Reuters
www.reuters.com - October 2 at 10:05 PM
Sorrento sets sales agreement for up to $75M in stockSorrento sets sales agreement for up to $75M in stock
seekingalpha.com - October 1 at 9:12 PM
Scilex Holding Company Strengthens Board of Directors with Appointment of Two Highly Accomplished Pharmaceutical and Biotechnology Executives, Scott Whitcup, M.D. and Elizabeth CzerepakScilex Holding Company Strengthens Board of Directors with Appointment of Two Highly Accomplished Pharmaceutical and Biotechnology Executives, Scott Whitcup, M.D. and Elizabeth Czerepak
finance.yahoo.com - September 30 at 7:10 AM
Scilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public OfferingScilex Holding Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
finance.yahoo.com - September 23 at 8:09 AM
Those Who Purchased Sorrento Therapeutics (NASDAQ:SRNE) Shares Three Years Ago Have A 67% Loss To Show For ItThose Who Purchased Sorrento Therapeutics (NASDAQ:SRNE) Shares Three Years Ago Have A 67% Loss To Show For It
finance.yahoo.com - August 14 at 8:04 PM
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseSorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 2 at 12:45 AM
Moving Average Crossover Alert: Sorrento TherapeuticsMoving Average Crossover Alert: Sorrento Therapeutics
finance.yahoo.com - July 29 at 11:23 AM
Sorrento Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and WarrantsSorrento Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Warrants
finance.yahoo.com - July 2 at 6:39 PM
Implied Volatility Surging for Sorrento (SRNE) Stock OptionsImplied Volatility Surging for Sorrento (SRNE) Stock Options
finance.yahoo.com - July 1 at 6:54 PM
Sorrento Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsSorrento Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
www.benzinga.com - June 28 at 6:35 PM
Sorrento Therapeutics down 26% premarket on pricing equity offeringSorrento Therapeutics down 26% premarket on pricing equity offering
seekingalpha.com - June 28 at 6:35 PM
Sorrento Therapeutics News: SRNE Stock Tanks on Equity OfferingSorrento Therapeutics News: SRNE Stock Tanks on Equity Offering
investorplace.com - June 28 at 12:39 PM
Sorrento Therapeutics launches equity offering; shares down 17% premarketSorrento Therapeutics launches equity offering; shares down 17% premarket
seekingalpha.com - June 28 at 8:25 AM
Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and WarrantsSorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
finance.yahoo.com - June 28 at 8:25 AM
Stacking The Deck: Henry Ji Is Setting The Stage For A Sorrento Therapeutics BreakoutStacking The Deck: Henry Ji Is Setting The Stage For A Sorrento Therapeutics Breakout
seekingalpha.com - June 20 at 7:50 PM
Sorrento +5% on positive resiniferatoxin dataSorrento +5% on positive resiniferatoxin data
seekingalpha.com - June 19 at 7:56 PM
Sorrento Therapeutics Shares Move On RTX Trial UpdateSorrento Therapeutics Shares Move On RTX Trial Update
finance.yahoo.com - June 19 at 7:56 PM
Sorrento Therapeutics Updates Positive Results of Phase 1b Resiniferatoxin (RTX) in Knee Osteoarthritis Pain TrialSorrento Therapeutics Updates Positive Results of Phase 1b Resiniferatoxin (RTX) in Knee Osteoarthritis Pain Trial
finance.yahoo.com - June 19 at 8:43 AM
Sorrento Provides Updates on CD38 Immunotherapies and Implementation of Disruptive GMP Manufacturing for “Off-The-Shelf” Cell Therapy Sorrento Provides Updates on CD38 Immunotherapies and Implementation of Disruptive GMP Manufacturing for “Off-The-Shelf” Cell Therapy 
finance.yahoo.com - June 19 at 8:43 AM
Sorrento Therapeutics -6.3% as Oaktree files for share offeringSorrento Therapeutics -6.3% as Oaktree files for share offering
seekingalpha.com - June 17 at 8:02 PM
Sorrento Therapeutics to Present at the JMP Securities Life Sciences Conference in New York (NY)Sorrento Therapeutics to Present at the JMP Securities Life Sciences Conference in New York (NY)
finance.yahoo.com - June 14 at 8:46 AM
Scilex HoldingScilex Holding
www.benzinga.com - June 13 at 12:59 PM
Sorrento Therapeutics could IPO its Scilex subsidiarySorrento Therapeutics could IPO its Scilex subsidiary
seekingalpha.com - June 12 at 5:43 PM
Sorrento Therapeutics Could IPO Its Scilex UnitSorrento Therapeutics Could IPO Its Scilex Unit
www.benzinga.com - June 12 at 10:18 AM
Sorrento to Explore Potential Initial Public Offering of Scilex Holding CompanySorrento to Explore Potential Initial Public Offering of Scilex Holding Company
finance.yahoo.com - June 12 at 10:18 AM
Sorrento to accelerate human IND filing of resiniferatoxin for neuropathic painSorrento to accelerate human IND filing of resiniferatoxin for neuropathic pain
seekingalpha.com - June 10 at 8:33 AM
Positive Feline Clinical Trial Outcome Motivates Sorrento Therapeutics to Accelerate Human IND Filing of Resiniferatoxin (RTX) for Prolonged Non-Opioid Control of Post-Amputation Neuropathic PainPositive Feline Clinical Trial Outcome Motivates Sorrento Therapeutics to Accelerate Human IND Filing of Resiniferatoxin (RTX) for Prolonged Non-Opioid Control of Post-Amputation Neuropathic Pain
finance.yahoo.com - June 10 at 8:33 AM
Scilex Holding Announces Strong ZTlido Sales Growth After Successful Post-Merger IntegrationScilex Holding Announces Strong ZTlido Sales Growth After Successful Post-Merger Integration
finance.yahoo.com - June 5 at 8:18 AM
Sorrento Announces Cannabidiol (CBD) Global Joint Ventures and Commercial Strategic PartnershipsSorrento Announces Cannabidiol (CBD) Global Joint Ventures and Commercial Strategic Partnerships
finance.yahoo.com - June 4 at 8:25 AM
Sorrento Therapeutics to Present at 20th Annual B. Riley FBR Investor Conference in Los Angeles (ca).Sorrento Therapeutics to Present at 20th Annual B. Riley FBR Investor Conference in Los Angeles (ca).
finance.yahoo.com - May 21 at 7:26 PM
Options Traders Expect Huge Moves in Sorrento (SRNE) StockOptions Traders Expect Huge Moves in Sorrento (SRNE) Stock
finance.yahoo.com - May 21 at 7:01 AM
Whats in Store for Sorrento (SRNE) This Earnings Season?What's in Store for Sorrento (SRNE) This Earnings Season?
www.nasdaq.com - May 3 at 7:14 PM
Sorrento establishes CBD unit; shares up 3%Sorrento establishes CBD unit; shares up 3%
seekingalpha.com - April 16 at 7:44 PM
Sorrento Establishes Business Unit to Address Market Opportunity for Proprietary Water Soluble Cannabidiol (CBD) FormulationsSorrento Establishes Business Unit to Address Market Opportunity for Proprietary Water Soluble Cannabidiol (CBD) Formulations
finance.yahoo.com - April 16 at 7:44 PM
Sorrento Therapeutics Expands Resiniferatoxin (RTX) Clinical Development Program to Life-Threatening Cardiovascular Diseases With Completion of Major Animal Toxicology StudySorrento Therapeutics Expands Resiniferatoxin (RTX) Clinical Development Program to Life-Threatening Cardiovascular Diseases With Completion of Major Animal Toxicology Study
finance.yahoo.com - April 15 at 7:20 AM
Sorrento up 6% on encouraging resiniferatoxin dataSorrento up 6% on encouraging resiniferatoxin data
seekingalpha.com - April 10 at 8:24 PM
Here's Why Sorrento Therapeutics Soared 134% in MarchHere's Why Sorrento Therapeutics Soared 134% in March
finance.yahoo.com - April 9 at 10:15 PM
Sorrento sues Soon-Shiong over "catch and kill" schemeSorrento sues Soon-Shiong over "catch and kill" scheme
seekingalpha.com - April 5 at 7:48 PM
Biotech Firms Strive to Combat the Growing Burden of Diseases With Innovative TechnologiesBiotech Firms Strive to Combat the Growing Burden of Diseases With Innovative Technologies
www.marketwatch.com - April 4 at 8:03 PM
Are Options Traders Betting on a Big Move in Sorrento Therapeutics (SRNE) Stock?Are Options Traders Betting on a Big Move in Sorrento Therapeutics (SRNE) Stock?
finance.yahoo.com - April 4 at 8:03 PM
Sorrento Therapeutics sues Soon-Shiong over alleged cancer drug schemeSorrento Therapeutics sues Soon-Shiong over alleged cancer drug scheme
finance.yahoo.com - April 4 at 8:03 PM
Sorrento Therapeutics sues billionaire Soon-Shiong over development of cancer drugSorrento Therapeutics sues billionaire Soon-Shiong over development of cancer drug
www.marketwatch.com - April 3 at 8:00 PM
Patrick Soon-Shiong accused of cancer drug ‘catch and kill’Patrick Soon-Shiong accused of cancer drug ‘catch and kill’
finance.yahoo.com - April 3 at 8:00 PM
Sorrento Therapeutics: With Many Stock Catalysts, It Is Not Risk-FreeSorrento Therapeutics: With Many Stock Catalysts, It Is Not Risk-Free
seekingalpha.com - March 27 at 7:47 PM
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Featured Article: Cost of Capital

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel